chr14-64065525-G-A
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_182914.3(SYNE2):c.10306G>A(p.Gly3436Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000936 in 1,613,966 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G3436G) has been classified as Likely benign.
Frequency
Consequence
NM_182914.3 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant Emery-Dreifuss muscular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Emery-Dreifuss muscular dystrophy 5, autosomal dominantInheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics
- left ventricular noncompactionInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_182914.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SYNE2 | NM_182914.3 | MANE Select | c.10306G>A | p.Gly3436Ser | missense | Exon 51 of 116 | NP_878918.2 | ||
| SYNE2 | NM_015180.6 | c.10306G>A | p.Gly3436Ser | missense | Exon 51 of 115 | NP_055995.4 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SYNE2 | ENST00000555002.6 | TSL:1 MANE Select | c.10306G>A | p.Gly3436Ser | missense | Exon 51 of 116 | ENSP00000450831.2 | ||
| SYNE2 | ENST00000344113.8 | TSL:1 | c.10306G>A | p.Gly3436Ser | missense | Exon 51 of 115 | ENSP00000341781.4 | ||
| SYNE2 | ENST00000358025.7 | TSL:5 | c.10306G>A | p.Gly3436Ser | missense | Exon 51 of 116 | ENSP00000350719.3 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152110Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000445 AC: 111AN: 249480 AF XY: 0.000318 show subpopulations
GnomAD4 exome AF: 0.0000937 AC: 137AN: 1461856Hom.: 0 Cov.: 32 AF XY: 0.0000729 AC XY: 53AN XY: 727232 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152110Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74292 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:2
The c.10306G>A (p.G3436S) alteration is located in exon 51 (coding exon 50) of the SYNE2 gene. This alteration results from a G to A substitution at nucleotide position 10306, causing the glycine (G) at amino acid position 3436 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Emery-Dreifuss muscular dystrophy 5, autosomal dominant Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at